JPMorgan Chase & Co’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-607,049
| Closed | -$4.05M | – | 6827 |
|
|
2023
Q3 | $4.05M | Sell |
607,049
-42,943
| -7% | -$286K | ﹤0.01% | 2554 |
|
|
2023
Q2 | $5.89M | Buy |
649,992
+581,750
| +852% | +$5.27M | ﹤0.01% | 2384 |
|
|
2023
Q1 | $496K | Sell |
68,242
-57,004
| -46% | -$414K | ﹤0.01% | 3836 |
|
|
2022
Q4 | $914K | Buy |
125,246
+84,438
| +207% | +$616K | ﹤0.01% | 3412 |
|
|
2022
Q3 | $315K | Buy |
40,808
+1,032
| +3% | +$7.97K | ﹤0.01% | 3974 |
|
|
2022
Q2 | $271K | Buy |
39,776
+19,616
| +97% | +$134K | ﹤0.01% | 4182 |
|
|
2022
Q1 | $160K | Sell |
20,160
-16,227
| -45% | -$129K | ﹤0.01% | 4547 |
|
|
2021
Q4 | $204K | Buy |
+36,387
| New | +$204K | ﹤0.01% | 4526 |
|